FDA 483 - Dr. Peter Szmuk - April 17, 2015
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Dr. Peter Szmuk, a Principal Investigator in Dallas, TX, was cited for significant deficiencies during an FDA inspection related to clinical investigations. The inspection revealed failures in obtaining legally effective informed consent, ensuring all research activity changes were IRB-approved, maintaining adequate case histories, and conducting the investigation in accordance with the approved protocol. These issues indicate a lack of proper oversight and adherence to regulatory requirements for human subject protection and data integrity.
ID · 3d87a747-2a1a-4a17-ad57-280d7e933562